News
Our latest moves
All
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
October 24, 2024
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
October 24, 2024
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
October 24, 2024
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
October 24, 2024
Dyno Therapeutics to Accelerate Design of High-Performance Biological Sequences Using NVIDIA AI
Announcements
May 9, 2024
Dyno Therapeutics to Accelerate Design of High-Performance Biological Sequences Using NVIDIA AI
Announcements
May 9, 2024
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence
Announcements
May 19, 2023
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence
Announcements
May 19, 2023
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Low-N OpenFold fine-tuning improves peptide design without additional structures
Publications
NeurIPS MLSB
October 4, 2024
Low-N OpenFold fine-tuning improves peptide design without additional structures
Publications
NeurIPS MLSB
October 4, 2024
Contrastive losses as generalized models of global epistasis
Publications
38th Conference on Neural Information Processing Systems
May 1, 2024
Contrastive losses as generalized models of global epistasis
Publications
38th Conference on Neural Information Processing Systems
May 1, 2024
Bionemo Framework: A Modular, High-Performance Library For AI Model Development In Drug Discovery
Publications
Arxiv
May 1, 2024
Bionemo Framework: A Modular, High-Performance Library For AI Model Development In Drug Discovery
Publications
Arxiv
May 1, 2024
Beyond the training set: an intuitive method for detecting distribution shift in model-based optimization
Publications
Arxiv
November 9, 2023
Beyond the training set: an intuitive method for detecting distribution shift in model-based optimization
Publications
Arxiv
November 9, 2023
Generative design for gene therapy: An in vivo validated method
Publications
NeurIPS GenBio
October 27, 2023
Generative design for gene therapy: An in vivo validated method
Publications
NeurIPS GenBio
October 27, 2023
Forecasting labels under distribution-shift for machine-guided sequence design
Publications
PMLR
August 3, 2023
Forecasting labels under distribution-shift for machine-guided sequence design
Publications
PMLR
August 3, 2023
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
The Endpoints 11: They've got mad money and huge ambitions. It's time to go big or go home
Press
Endpoints News
September 22, 2021
The Endpoints 11: They've got mad money and huge ambitions. It's time to go big or go home
Press
Endpoints News
September 22, 2021
Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months
Press
Business Insider
August 2, 2021
Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months
Press
Business Insider
August 2, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021